These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23192400)

  • 1. The impact of hepatitis A virus infection on hepatitis C virus infection: a competitive exclusion hypothesis.
    Amaku M; Coutinho FA; Chaib E; Massad E
    Bull Math Biol; 2013 Jan; 75(1):82-93. PubMed ID: 23192400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
    Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
    J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and analysis of HAV-HEV, HGV infection in patients with viral hepatitis].
    Xiong LS; Cui SF; Zhou JG; Xing Y
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):395-6. PubMed ID: 15268800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    J Viral Hepat; 2007 Nov; 14 Suppl 1():77-81. PubMed ID: 17958647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
    Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
    J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis.
    Manfredi R; Dentale N; Calza L
    Int J STD AIDS; 2012 Mar; 23(3):e48-50. PubMed ID: 22581898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The extrahepatic site of hepatitis C virus: clinical manifestations and prognostic value].
    Krel' PE; Tsinzerling OD
    Ter Arkh; 2009; 81(11):63-8. PubMed ID: 20141018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamical analysis on a chronic hepatitis C virus infection model with immune response.
    Li J; Men K; Yang Y; Li D
    J Theor Biol; 2015 Jan; 365():337-46. PubMed ID: 25451526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
    Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A viral load in relation to severity of the infection.
    Fujiwara K; Kojima H; Yasui S; Okitsu K; Yonemitsu Y; Omata M; Yokosuka O
    J Med Virol; 2011 Feb; 83(2):201-7. PubMed ID: 21181913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High and persistent excretion of hepatitis A virus in immunocompetent patients.
    Tjon GM; Coutinho RA; van den Hoek A; Esman S; Wijkmans CJ; Hoebe CJ; Wolters B; Swaan C; Geskus RB; Dukers N; Bruisten SM
    J Med Virol; 2006 Nov; 78(11):1398-405. PubMed ID: 16998883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and the immune system: a concise review.
    Gremion C; Cerny A
    Rev Med Virol; 2005; 15(4):235-68. PubMed ID: 15782389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.
    Pal S; Sullivan DG; Kim S; Lai KK; Kae J; Cotler SJ; Carithers RL; Wood BL; Perkins JD; Gretch DR
    Gastroenterology; 2006 Apr; 130(4):1107-16. PubMed ID: 16618405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV immunopathogenesis: virus-induced strategies against host immunity.
    Szabo G; Dolganiuc A
    Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.